DOI: 10.3201/eid2108.150273; PMCID: PMC4517703
© 2015, Centers for Disease Control and Prevention (CDC). All rights reserved.
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being reported from Europe. Few data on MRMP are available in the United States. Using genotypic and phenotypic methods, we detected high-level MRMP in 13.2% of 91 M. pneumoniae–positive specimens from 6 US locations.
Emerging Infectious Diseases
MIC; Mycoplasma pneumoniae; United States; antimicrobial resistance; bacteria; children; macrolide
Zheng, X., Lee, S., Selvarangan, R., Qin, X., Tang, Y., Stiles, J., Hong, T., Todd, K., Ratliff, A. E., Crabb, D. M., Xiao, L., Atkinson, T. P., Waites, K. B. Macrolide-resistant Mycoplasma pneumoniae, United States Emerging Infectious Diseases 21, 1470-1472 (2015).